Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine
- PMID: 22650354
- DOI: 10.1111/j.1747-0285.2012.01423.x
Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine
Abstract
The self-assembling protein nanoparticle (SAPN) is an antigen-presenting system that has been shown to be suitable for use as a vaccine platform. The SAPN scaffold is based on the principles of icosahedral symmetry, beginning from a monomeric chain that self-assembles into an ordered oligomeric state. The monomeric chain contains two covalently linked α-helical coiled-coil domains, an N-terminal de novo-designed pentameric tryptophan zipper and a C-terminal de novo-designed trimeric leucine zipper, which assemble along the internal symmetry axes of an icosahedron. In this study, we incorporated the membrane proximal external region (MPER) of HIV-1 gp41 from HXB2 into the N-terminal pentamer, referred to as MPER-SAPN, attempting to reproduce the α-helical state of the 4E10 epitope while maintaining a structurally less-constrained 2F5 epitope. Sprague-Dawley rats were immunized with MPER-SAPNs, and their sera were analyzed for induced humoral anti-HIV-1 responses. We show that high membrane proximal external region-specific titers can be raised via the repetitive antigen display of MPER on the SAPN without the need for adjuvant. However, none of the sera displayed a detectable neutralizing activity against HIV-1. Thus, 4E10- and 2F5-like neutralizing antibodies could not be elicited by MPER conformationally restrained in the SAPN context.
© 2012 John Wiley & Sons A/S.
Similar articles
-
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.AIDS. 2009 Oct 23;23(16):2069-77. doi: 10.1097/QAD.0b013e32832faea5. AIDS. 2009. PMID: 19710597
-
Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265. Epub 2011 Jan 15. AIDS Res Hum Retroviruses. 2011. PMID: 21142698
-
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.J Virol. 2005 Jan;79(2):1252-61. doi: 10.1128/JVI.79.2.1252-1261.2005. J Virol. 2005. PMID: 15613352 Free PMC article.
-
Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.Curr Opin HIV AIDS. 2017 May;12(3):250-256. doi: 10.1097/COH.0000000000000364. Curr Opin HIV AIDS. 2017. PMID: 28422789 Review.
-
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents. doi: 10.1128/MMBR.00020-07. Microbiol Mol Biol Rev. 2008. PMID: 18322034 Free PMC article. Review.
Cited by
-
Optimizing the design of protein nanoparticles as carriers for vaccine applications.Nanomedicine. 2015 Oct;11(7):1705-13. doi: 10.1016/j.nano.2015.05.003. Epub 2015 Jun 4. Nanomedicine. 2015. PMID: 26051652 Free PMC article.
-
Development of Self-Assembled Protein Nanocage Spatially Functionalized with HA Stalk as a Broadly Cross-Reactive Influenza Vaccine Platform.ACS Nano. 2023 Dec 26;17(24):25045-25060. doi: 10.1021/acsnano.3c07669. Epub 2023 Dec 12. ACS Nano. 2023. PMID: 38084728 Free PMC article.
-
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.Vaccine. 2020 Nov 10;38(48):7612-7628. doi: 10.1016/j.vaccine.2020.10.016. Epub 2020 Oct 9. Vaccine. 2020. PMID: 33082015 Free PMC article.
-
Principles Governing the Self-Assembly of Coiled-Coil Protein Nanoparticles.Biophys J. 2016 Feb 2;110(3):646-660. doi: 10.1016/j.bpj.2015.10.057. Biophys J. 2016. PMID: 26840729 Free PMC article.
-
Protein nanovaccine confers robust immunity against Toxoplasma.NPJ Vaccines. 2017 Sep 5;2:24. doi: 10.1038/s41541-017-0024-6. eCollection 2017. NPJ Vaccines. 2017. PMID: 29263879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical